Oracle-funded study improves treatment prospects for cancer patients
Read the ICR’s latest blog post about the success of our recent Oracle-funded study into combining radiotherapies with viruses to improve treatment prospects for cancer patients.
Oracle-funded scientists at the ICR and The Royal Marsden NHS Foundation Trust combined the oncolytic reovirus RT3D, with radiotherapy to treat melanoma, and found that the combination was much more effective than separate treatments.
Read the full report here:
Jamie Theakston Announces He is Cancer-Free After Laryngeal Cancer Treatment
Heart Breakfast’s much-loved presenter, Jamie Theakston, has shared the incredible news that he is now cancer free! After completing treatment for stage one laryngeal cancer – cancer of the voice…
Mark Steele – Unforgettable evening of humour, resilience, and personal storytelling.
British comedian Mark Steele and military leader Major General Julian Buczacki are joining forces for an unforgettable evening of humour.
Revolutionising Head and Neck Cancer Care: The EVEREST-HN Project
Oracle HNCUK is thrilled to support the innovative EVEREST-HN project, a game-changing study led by The Royal Marsden. Now entering its feasibility trial phase, this groundbreaking research is set to transform…
Research Large Grants Programme Opportunity
We’re offering up to £300,000 over three years to support innovative, hypothesis-driven research projects.
12 Days of Christmas Winter Appeal 2024
Counting down 12 days of Christmas with fundraising ideas and keeping in touch with Oracle.
Petition to improve HPV Vaccine Uptake
Petition urges increase to HPV vaccine uptake and reduce preventable cancers caused by HPV.
Seeking Specialists for Late Effects Guidelines
Develop national best practice guidelines for managing late effects of head and neck cancer treatment.